Development of [(124/125)I]IAZA as a New Proteinopathy Imaging Agent for Alzheimer’s Disease

Radioiodinated imaging agents for Aβ amyloid plaque imaging in Alzheimer’s disease (AD) patients have not been actively pursued. Our previous studies employed the “diaza” derivatives [(11)C]TAZA and [(18)F]flotaza in order to develop successful positron emission tomography (PET) imaging agents for A...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Thrisha T., Iguban, Michael H., Melkonyan, Lusine L., Shergill, Jasmine, Liang, Christopher, Mukherjee, Jogeshwar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863004/
https://www.ncbi.nlm.nih.gov/pubmed/36677925
http://dx.doi.org/10.3390/molecules28020865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863004/
https://www.ncbi.nlm.nih.gov/pubmed/36677925
http://dx.doi.org/10.3390/molecules28020865

Ejemplares similares